EspaƱol
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 66 for your search:
Cancer Type/Condition:  breast cancer, male breast cancer
Trial Type:  Screening, Prevention
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Screening
Status: Active
Age: 25 to 70
Sponsor: Other
Protocol IDs: DBCG07MRBRCA, NCT00413491

2.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 40-to 60
Sponsor: Other
Protocol IDs: 2008BAI57B04, NCT01698164

3.

Phase: Phase III
Type: Prevention
Status: Active
Age: 30 to 75
Sponsor: Other
Protocol IDs: GD-10-08, NCT00808522

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: GAL 01, NCT01357772

5.

Phase: Phase III
Type: Screening
Status: Active
Age: 5 to 71
Sponsor: Other
Protocol IDs: CSET2011/1748, NCT01464086

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Approved-not yet active
Age: 25 to 55
Sponsor: NCI, Other
Protocol IDs: A211102, U10CA031946, NCI-2013-00995, NCT01905046

7.

Phase: Phase III
Type: Diagnostic, Health services research, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FMSU2013-004A, NCT02156258

8.

Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FT3.6k-2006, NCT00419679

9.

Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FER2k, NCT00419900

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200806, NCT01425476

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 200807-001, NCT01769625

12.

Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 90
Sponsor: Other
Protocol IDs: 102/07 (HT4351), NCT00496288

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 35 to 55
Sponsor: Other
Protocol IDs: V0407, CHRMS#: 05-059, NCT00914017

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 25 and over
Sponsor: NCI, Other
Protocol IDs: 08218, R01CA140245-01, NCI-2010-01976, NCT01196936

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 to 49
Sponsor: Other
Protocol IDs: 12377, NCT01276704

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-0794, NCI-2012-00037, KG09 1020, NCT01471106

17.

Phase: Phase II
Type: Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: TOMOSEIN-1104, 2011-002051-34, NCT01612650

18.

Phase: Phase II
Type: Prevention
Status: Active
Age: Not Specified
Sponsor: Other
Protocol IDs: Institut Jules Bordet, NCT01658956

19.

Phase: Phase II
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DFG NE 1635/2-1, NCT01741883

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 75 and under
Sponsor: Other
Protocol IDs: 1RO1 CA1615301A1, 12-0080-04, NCT01761877

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00859, 12-474, 12-267, N01-CN-2012-00034, AAAK6752, MSKCC-12-267, H-33017, 2011-0766, MDA10-16-01, P30CA016672, N01CN00034, N01CN35159, NCT01849250

22.

Phase: Phase II
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-003703-35, NCT01898312

23.

Phase: Phase II
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H13-03090, NCT02006979

24.

Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 45
Sponsor: NCI, Other
Protocol IDs: 1300000596, 1R01CA172444-01A1, NCT02028221

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 45 to 70
Sponsor: Other
Protocol IDs: STUDY00000703, NCT02101970
1    
New Search